, Tracking Stock Market Picks
Enter Symbol:
Navidea Biopharmaceuticals Inc. (NAVB) [hlAlert]

down 62.18 %

Neoprobe Corporation (NEOP) rated Buy with price target $9 by Morgan Joseph

Posted on: Friday,  May 13, 2011  9:25 AM ET by Morgan Joseph

Morgan Joseph rated Buy Navidea Biopharmaceuticals Inc. (AMEX: NAVB) on 05/13/2011, when the stock price was $4.76. Since
then, Navidea Biopharmaceuticals Inc. has lost 62.18% as of 08/27/2015's recent price of $1.80.
If you would have followed this Morgan Joseph's recommendation on NAVB, you would have lost 62.18% of your investment in 1567 days.

Neoprobe Corporation (Neoprobe) is a biomedical company that develops and commercializes products that enhance patient care and improve patient outcome by meeting the intraoperative diagnostic information needs of physicians and therapeutic treatment needs of patients. The Company markets two lines of medical devices, which includes its neoprobe GDS gamma detection systems and the Quantix line of blood flow measurement devices of its subsidiary, Cardiosonix Ltd. In addition to its medical device products, it has two radiopharmaceutical products, Lymphoseek and RIGScan CR, in advanced phases of clinical development.

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2011 9:25 AM Buy
4.76 9.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy